nodes	percent_of_prediction	percent_of_DWPC	metapath
Zopiclone—CYP2C9—Estropipate—osteoporosis	0.0682	0.12	CbGbCtD
Zopiclone—CYP2C8—Raloxifene—osteoporosis	0.0652	0.115	CbGbCtD
Zopiclone—CYP2C8—Ethinyl Estradiol—osteoporosis	0.063	0.111	CbGbCtD
Zopiclone—CYP2C8—Cholecalciferol—osteoporosis	0.0504	0.0884	CbGbCtD
Zopiclone—CYP2C8—Estradiol—osteoporosis	0.0406	0.0713	CbGbCtD
Zopiclone—CYP3A4—Estropipate—osteoporosis	0.0397	0.0696	CbGbCtD
Zopiclone—CYP3A4—Calcitriol—osteoporosis	0.0397	0.0696	CbGbCtD
Zopiclone—CYP2C9—Cholecalciferol—osteoporosis	0.0351	0.0617	CbGbCtD
Zopiclone—CYP3A4—Ergocalciferol—osteoporosis	0.0317	0.0557	CbGbCtD
Zopiclone—CYP2C9—Estradiol—osteoporosis	0.0283	0.0497	CbGbCtD
Zopiclone—CYP3A4—Raloxifene—osteoporosis	0.0265	0.0465	CbGbCtD
Zopiclone—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0256	0.0449	CbGbCtD
Zopiclone—CYP3A4—Cholecalciferol—osteoporosis	0.0204	0.0359	CbGbCtD
Zopiclone—CYP3A4—Conjugated Estrogens—osteoporosis	0.0188	0.0329	CbGbCtD
Zopiclone—CYP3A4—Estradiol—osteoporosis	0.0165	0.0289	CbGbCtD
Zopiclone—Pharyngitis—Estradiol—osteoporosis	0.000267	0.000625	CcSEcCtD
Zopiclone—Hypersensitivity—Estropipate—osteoporosis	0.000266	0.000623	CcSEcCtD
Zopiclone—Vomiting—Etidronic acid—osteoporosis	0.000266	0.000622	CcSEcCtD
Zopiclone—Oedema peripheral—Estradiol—osteoporosis	0.000265	0.00062	CcSEcCtD
Zopiclone—Tachycardia—Pamidronate—osteoporosis	0.000265	0.00062	CcSEcCtD
Zopiclone—Rash—Etidronic acid—osteoporosis	0.000263	0.000616	CcSEcCtD
Zopiclone—Convulsion—Zoledronate—osteoporosis	0.000263	0.000616	CcSEcCtD
Zopiclone—Dermatitis—Etidronic acid—osteoporosis	0.000263	0.000616	CcSEcCtD
Zopiclone—Vertigo—Conjugated Estrogens—osteoporosis	0.000263	0.000615	CcSEcCtD
Zopiclone—Hyperhidrosis—Pamidronate—osteoporosis	0.000263	0.000614	CcSEcCtD
Zopiclone—Hypertension—Zoledronate—osteoporosis	0.000262	0.000614	CcSEcCtD
Zopiclone—Hypersensitivity—Alendronate—osteoporosis	0.000262	0.000614	CcSEcCtD
Zopiclone—Headache—Etidronic acid—osteoporosis	0.000262	0.000612	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Risedronate—osteoporosis	0.00026	0.000609	CcSEcCtD
Zopiclone—Asthenia—Estropipate—osteoporosis	0.000259	0.000607	CcSEcCtD
Zopiclone—Anorexia—Pamidronate—osteoporosis	0.000259	0.000606	CcSEcCtD
Zopiclone—Chest pain—Zoledronate—osteoporosis	0.000259	0.000605	CcSEcCtD
Zopiclone—Myalgia—Zoledronate—osteoporosis	0.000259	0.000605	CcSEcCtD
Zopiclone—Palpitations—Conjugated Estrogens—osteoporosis	0.000259	0.000605	CcSEcCtD
Zopiclone—Insomnia—Risedronate—osteoporosis	0.000258	0.000604	CcSEcCtD
Zopiclone—Anxiety—Zoledronate—osteoporosis	0.000258	0.000603	CcSEcCtD
Zopiclone—Paraesthesia—Risedronate—osteoporosis	0.000256	0.0006	CcSEcCtD
Zopiclone—Pruritus—Estropipate—osteoporosis	0.000256	0.000598	CcSEcCtD
Zopiclone—Discomfort—Zoledronate—osteoporosis	0.000256	0.000598	CcSEcCtD
Zopiclone—Asthenia—Alendronate—osteoporosis	0.000255	0.000598	CcSEcCtD
Zopiclone—Hypersensitivity—Ibandronate—osteoporosis	0.000255	0.000597	CcSEcCtD
Zopiclone—Dyspnoea—Risedronate—osteoporosis	0.000255	0.000596	CcSEcCtD
Zopiclone—Erythema multiforme—Estradiol—osteoporosis	0.000254	0.000595	CcSEcCtD
Zopiclone—Convulsion—Conjugated Estrogens—osteoporosis	0.000254	0.000593	CcSEcCtD
Zopiclone—Dry mouth—Zoledronate—osteoporosis	0.000253	0.000592	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000253	0.000592	CcSEcCtD
Zopiclone—Fatigue—Ethinyl Estradiol—osteoporosis	0.000253	0.000591	CcSEcCtD
Zopiclone—Pruritus—Alendronate—osteoporosis	0.000252	0.000589	CcSEcCtD
Zopiclone—Dyspepsia—Risedronate—osteoporosis	0.000251	0.000588	CcSEcCtD
Zopiclone—Tinnitus—Estradiol—osteoporosis	0.000251	0.000587	CcSEcCtD
Zopiclone—Constipation—Ethinyl Estradiol—osteoporosis	0.000251	0.000586	CcSEcCtD
Zopiclone—Confusional state—Zoledronate—osteoporosis	0.00025	0.000585	CcSEcCtD
Zopiclone—Hypersensitivity—Calcitriol—osteoporosis	0.00025	0.000585	CcSEcCtD
Zopiclone—Chest pain—Conjugated Estrogens—osteoporosis	0.000249	0.000583	CcSEcCtD
Zopiclone—Myalgia—Conjugated Estrogens—osteoporosis	0.000249	0.000583	CcSEcCtD
Zopiclone—Asthenia—Ibandronate—osteoporosis	0.000249	0.000582	CcSEcCtD
Zopiclone—Anxiety—Conjugated Estrogens—osteoporosis	0.000248	0.000581	CcSEcCtD
Zopiclone—Nausea—Etidronic acid—osteoporosis	0.000248	0.000581	CcSEcCtD
Zopiclone—Anaphylactic shock—Zoledronate—osteoporosis	0.000248	0.00058	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000247	0.000579	CcSEcCtD
Zopiclone—Diarrhoea—Estropipate—osteoporosis	0.000247	0.000579	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Risedronate—osteoporosis	0.000247	0.000577	CcSEcCtD
Zopiclone—Infection—Zoledronate—osteoporosis	0.000246	0.000577	CcSEcCtD
Zopiclone—Fatigue—Risedronate—osteoporosis	0.000246	0.000576	CcSEcCtD
Zopiclone—Insomnia—Pamidronate—osteoporosis	0.000246	0.000575	CcSEcCtD
Zopiclone—Pruritus—Ibandronate—osteoporosis	0.000245	0.000574	CcSEcCtD
Zopiclone—Constipation—Risedronate—osteoporosis	0.000244	0.000571	CcSEcCtD
Zopiclone—Pain—Risedronate—osteoporosis	0.000244	0.000571	CcSEcCtD
Zopiclone—Paraesthesia—Pamidronate—osteoporosis	0.000244	0.00057	CcSEcCtD
Zopiclone—Diarrhoea—Alendronate—osteoporosis	0.000244	0.00057	CcSEcCtD
Zopiclone—Asthenia—Calcitriol—osteoporosis	0.000243	0.00057	CcSEcCtD
Zopiclone—Dyspnoea—Pamidronate—osteoporosis	0.000242	0.000566	CcSEcCtD
Zopiclone—Tachycardia—Zoledronate—osteoporosis	0.000242	0.000566	CcSEcCtD
Zopiclone—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000241	0.000565	CcSEcCtD
Zopiclone—Chills—Estradiol—osteoporosis	0.000241	0.000565	CcSEcCtD
Zopiclone—Somnolence—Pamidronate—osteoporosis	0.000241	0.000565	CcSEcCtD
Zopiclone—Pruritus—Calcitriol—osteoporosis	0.00024	0.000562	CcSEcCtD
Zopiclone—Hyperhidrosis—Zoledronate—osteoporosis	0.00024	0.000561	CcSEcCtD
Zopiclone—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.00024	0.000561	CcSEcCtD
Zopiclone—Diarrhoea—Raloxifene—osteoporosis	0.00024	0.00056	CcSEcCtD
Zopiclone—Dyspepsia—Pamidronate—osteoporosis	0.000239	0.000559	CcSEcCtD
Zopiclone—Dizziness—Estropipate—osteoporosis	0.000239	0.000559	CcSEcCtD
Zopiclone—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000239	0.000559	CcSEcCtD
Zopiclone—Alopecia—Estradiol—osteoporosis	0.000238	0.000556	CcSEcCtD
Zopiclone—Infection—Conjugated Estrogens—osteoporosis	0.000237	0.000555	CcSEcCtD
Zopiclone—Diarrhoea—Ibandronate—osteoporosis	0.000237	0.000555	CcSEcCtD
Zopiclone—Anorexia—Zoledronate—osteoporosis	0.000236	0.000553	CcSEcCtD
Zopiclone—Decreased appetite—Pamidronate—osteoporosis	0.000236	0.000552	CcSEcCtD
Zopiclone—Dizziness—Alendronate—osteoporosis	0.000235	0.000551	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000234	0.000548	CcSEcCtD
Zopiclone—Fatigue—Pamidronate—osteoporosis	0.000234	0.000548	CcSEcCtD
Zopiclone—Gastrointestinal pain—Risedronate—osteoporosis	0.000234	0.000546	CcSEcCtD
Zopiclone—Tachycardia—Conjugated Estrogens—osteoporosis	0.000233	0.000545	CcSEcCtD
Zopiclone—Urticaria—Ethinyl Estradiol—osteoporosis	0.000233	0.000545	CcSEcCtD
Zopiclone—Constipation—Pamidronate—osteoporosis	0.000232	0.000543	CcSEcCtD
Zopiclone—Pain—Pamidronate—osteoporosis	0.000232	0.000543	CcSEcCtD
Zopiclone—Diarrhoea—Calcitriol—osteoporosis	0.000232	0.000543	CcSEcCtD
Zopiclone—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000232	0.000542	CcSEcCtD
Zopiclone—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000232	0.000542	CcSEcCtD
Zopiclone—Dizziness—Raloxifene—osteoporosis	0.000232	0.000542	CcSEcCtD
Zopiclone—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000231	0.00054	CcSEcCtD
Zopiclone—Tension—Estradiol—osteoporosis	0.00023	0.000538	CcSEcCtD
Zopiclone—Vomiting—Estropipate—osteoporosis	0.00023	0.000538	CcSEcCtD
Zopiclone—Dysgeusia—Estradiol—osteoporosis	0.000229	0.000537	CcSEcCtD
Zopiclone—Dizziness—Ibandronate—osteoporosis	0.000229	0.000536	CcSEcCtD
Zopiclone—Rash—Estropipate—osteoporosis	0.000228	0.000533	CcSEcCtD
Zopiclone—Dermatitis—Estropipate—osteoporosis	0.000228	0.000533	CcSEcCtD
Zopiclone—Anorexia—Conjugated Estrogens—osteoporosis	0.000228	0.000533	CcSEcCtD
Zopiclone—Nervousness—Estradiol—osteoporosis	0.000227	0.000532	CcSEcCtD
Zopiclone—Urticaria—Risedronate—osteoporosis	0.000227	0.000531	CcSEcCtD
Zopiclone—Back pain—Estradiol—osteoporosis	0.000227	0.00053	CcSEcCtD
Zopiclone—Headache—Estropipate—osteoporosis	0.000226	0.00053	CcSEcCtD
Zopiclone—Vomiting—Alendronate—osteoporosis	0.000226	0.00053	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000226	0.000529	CcSEcCtD
Zopiclone—Abdominal pain—Risedronate—osteoporosis	0.000226	0.000528	CcSEcCtD
Zopiclone—Body temperature increased—Risedronate—osteoporosis	0.000226	0.000528	CcSEcCtD
Zopiclone—Muscle spasms—Estradiol—osteoporosis	0.000225	0.000527	CcSEcCtD
Zopiclone—Rash—Alendronate—osteoporosis	0.000224	0.000525	CcSEcCtD
Zopiclone—Insomnia—Zoledronate—osteoporosis	0.000224	0.000525	CcSEcCtD
Zopiclone—Dermatitis—Alendronate—osteoporosis	0.000224	0.000525	CcSEcCtD
Zopiclone—Feeling abnormal—Pamidronate—osteoporosis	0.000224	0.000524	CcSEcCtD
Zopiclone—Headache—Alendronate—osteoporosis	0.000223	0.000522	CcSEcCtD
Zopiclone—Paraesthesia—Zoledronate—osteoporosis	0.000223	0.000521	CcSEcCtD
Zopiclone—Vomiting—Raloxifene—osteoporosis	0.000223	0.000521	CcSEcCtD
Zopiclone—Gastrointestinal pain—Pamidronate—osteoporosis	0.000222	0.00052	CcSEcCtD
Zopiclone—Dyspnoea—Zoledronate—osteoporosis	0.000221	0.000517	CcSEcCtD
Zopiclone—Rash—Raloxifene—osteoporosis	0.000221	0.000516	CcSEcCtD
Zopiclone—Dermatitis—Raloxifene—osteoporosis	0.000221	0.000516	CcSEcCtD
Zopiclone—Somnolence—Zoledronate—osteoporosis	0.000221	0.000516	CcSEcCtD
Zopiclone—Vomiting—Ibandronate—osteoporosis	0.00022	0.000516	CcSEcCtD
Zopiclone—Tremor—Estradiol—osteoporosis	0.000219	0.000513	CcSEcCtD
Zopiclone—Headache—Raloxifene—osteoporosis	0.000219	0.000513	CcSEcCtD
Zopiclone—Rash—Ibandronate—osteoporosis	0.000219	0.000511	CcSEcCtD
Zopiclone—Dermatitis—Ibandronate—osteoporosis	0.000218	0.000511	CcSEcCtD
Zopiclone—Dyspepsia—Zoledronate—osteoporosis	0.000218	0.000511	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000218	0.000509	CcSEcCtD
Zopiclone—Ill-defined disorder—Estradiol—osteoporosis	0.000217	0.000508	CcSEcCtD
Zopiclone—Headache—Ibandronate—osteoporosis	0.000217	0.000508	CcSEcCtD
Zopiclone—Insomnia—Conjugated Estrogens—osteoporosis	0.000216	0.000505	CcSEcCtD
Zopiclone—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000216	0.000505	CcSEcCtD
Zopiclone—Vomiting—Calcitriol—osteoporosis	0.000216	0.000505	CcSEcCtD
Zopiclone—Decreased appetite—Zoledronate—osteoporosis	0.000216	0.000504	CcSEcCtD
Zopiclone—Agitation—Estradiol—osteoporosis	0.000215	0.000504	CcSEcCtD
Zopiclone—Nausea—Estropipate—osteoporosis	0.000215	0.000502	CcSEcCtD
Zopiclone—Abdominal pain—Pamidronate—osteoporosis	0.000215	0.000502	CcSEcCtD
Zopiclone—Body temperature increased—Pamidronate—osteoporosis	0.000215	0.000502	CcSEcCtD
Zopiclone—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000214	0.000502	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000214	0.000501	CcSEcCtD
Zopiclone—Angioedema—Estradiol—osteoporosis	0.000214	0.000501	CcSEcCtD
Zopiclone—Rash—Calcitriol—osteoporosis	0.000214	0.000501	CcSEcCtD
Zopiclone—Fatigue—Zoledronate—osteoporosis	0.000214	0.0005	CcSEcCtD
Zopiclone—Dermatitis—Calcitriol—osteoporosis	0.000214	0.0005	CcSEcCtD
Zopiclone—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000213	0.000498	CcSEcCtD
Zopiclone—Headache—Calcitriol—osteoporosis	0.000213	0.000497	CcSEcCtD
Zopiclone—Somnolence—Conjugated Estrogens—osteoporosis	0.000212	0.000497	CcSEcCtD
Zopiclone—Pain—Zoledronate—osteoporosis	0.000212	0.000496	CcSEcCtD
Zopiclone—Constipation—Zoledronate—osteoporosis	0.000212	0.000496	CcSEcCtD
Zopiclone—Nausea—Alendronate—osteoporosis	0.000211	0.000495	CcSEcCtD
Zopiclone—Malaise—Estradiol—osteoporosis	0.000211	0.000494	CcSEcCtD
Zopiclone—Hypersensitivity—Risedronate—osteoporosis	0.00021	0.000492	CcSEcCtD
Zopiclone—Vertigo—Estradiol—osteoporosis	0.00021	0.000492	CcSEcCtD
Zopiclone—Dyspepsia—Conjugated Estrogens—osteoporosis	0.00021	0.000492	CcSEcCtD
Zopiclone—Asthenia—Ethinyl Estradiol—osteoporosis	0.00021	0.000492	CcSEcCtD
Zopiclone—Nausea—Raloxifene—osteoporosis	0.000208	0.000487	CcSEcCtD
Zopiclone—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000208	0.000486	CcSEcCtD
Zopiclone—Pruritus—Ethinyl Estradiol—osteoporosis	0.000207	0.000485	CcSEcCtD
Zopiclone—Palpitations—Estradiol—osteoporosis	0.000207	0.000484	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000206	0.000482	CcSEcCtD
Zopiclone—Fatigue—Conjugated Estrogens—osteoporosis	0.000206	0.000482	CcSEcCtD
Zopiclone—Nausea—Ibandronate—osteoporosis	0.000206	0.000482	CcSEcCtD
Zopiclone—Asthenia—Risedronate—osteoporosis	0.000205	0.000479	CcSEcCtD
Zopiclone—Feeling abnormal—Zoledronate—osteoporosis	0.000204	0.000478	CcSEcCtD
Zopiclone—Constipation—Conjugated Estrogens—osteoporosis	0.000204	0.000478	CcSEcCtD
Zopiclone—Pain—Conjugated Estrogens—osteoporosis	0.000204	0.000478	CcSEcCtD
Zopiclone—Gastrointestinal pain—Zoledronate—osteoporosis	0.000203	0.000475	CcSEcCtD
Zopiclone—Hypertension—Estradiol—osteoporosis	0.000202	0.000473	CcSEcCtD
Zopiclone—Pruritus—Risedronate—osteoporosis	0.000202	0.000473	CcSEcCtD
Zopiclone—Nausea—Calcitriol—osteoporosis	0.000202	0.000472	CcSEcCtD
Zopiclone—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.0002	0.000469	CcSEcCtD
Zopiclone—Hypersensitivity—Pamidronate—osteoporosis	0.0002	0.000468	CcSEcCtD
Zopiclone—Myalgia—Estradiol—osteoporosis	0.000199	0.000467	CcSEcCtD
Zopiclone—Chest pain—Estradiol—osteoporosis	0.000199	0.000467	CcSEcCtD
Zopiclone—Anxiety—Estradiol—osteoporosis	0.000199	0.000465	CcSEcCtD
Zopiclone—Urticaria—Zoledronate—osteoporosis	0.000197	0.000461	CcSEcCtD
Zopiclone—Discomfort—Estradiol—osteoporosis	0.000197	0.000461	CcSEcCtD
Zopiclone—Abdominal pain—Zoledronate—osteoporosis	0.000196	0.000459	CcSEcCtD
Zopiclone—Body temperature increased—Zoledronate—osteoporosis	0.000196	0.000459	CcSEcCtD
Zopiclone—Diarrhoea—Risedronate—osteoporosis	0.000195	0.000457	CcSEcCtD
Zopiclone—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000195	0.000457	CcSEcCtD
Zopiclone—Dry mouth—Estradiol—osteoporosis	0.000195	0.000456	CcSEcCtD
Zopiclone—Asthenia—Pamidronate—osteoporosis	0.000195	0.000456	CcSEcCtD
Zopiclone—Dizziness—Ethinyl Estradiol—osteoporosis	0.000194	0.000453	CcSEcCtD
Zopiclone—Confusional state—Estradiol—osteoporosis	0.000193	0.000451	CcSEcCtD
Zopiclone—Pruritus—Pamidronate—osteoporosis	0.000192	0.000449	CcSEcCtD
Zopiclone—Anaphylactic shock—Estradiol—osteoporosis	0.000191	0.000447	CcSEcCtD
Zopiclone—Infection—Estradiol—osteoporosis	0.00019	0.000444	CcSEcCtD
Zopiclone—Urticaria—Conjugated Estrogens—osteoporosis	0.00019	0.000444	CcSEcCtD
Zopiclone—Dizziness—Risedronate—osteoporosis	0.000189	0.000442	CcSEcCtD
Zopiclone—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000189	0.000442	CcSEcCtD
Zopiclone—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000189	0.000442	CcSEcCtD
Zopiclone—Tachycardia—Estradiol—osteoporosis	0.000187	0.000436	CcSEcCtD
Zopiclone—Vomiting—Ethinyl Estradiol—osteoporosis	0.000186	0.000436	CcSEcCtD
Zopiclone—Diarrhoea—Pamidronate—osteoporosis	0.000186	0.000435	CcSEcCtD
Zopiclone—Hyperhidrosis—Estradiol—osteoporosis	0.000185	0.000432	CcSEcCtD
Zopiclone—Rash—Ethinyl Estradiol—osteoporosis	0.000185	0.000432	CcSEcCtD
Zopiclone—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000185	0.000432	CcSEcCtD
Zopiclone—Headache—Ethinyl Estradiol—osteoporosis	0.000184	0.000429	CcSEcCtD
Zopiclone—Hypersensitivity—Zoledronate—osteoporosis	0.000183	0.000428	CcSEcCtD
Zopiclone—Vomiting—Risedronate—osteoporosis	0.000182	0.000425	CcSEcCtD
Zopiclone—Rash—Risedronate—osteoporosis	0.00018	0.000421	CcSEcCtD
Zopiclone—Dermatitis—Risedronate—osteoporosis	0.00018	0.000421	CcSEcCtD
Zopiclone—Dizziness—Pamidronate—osteoporosis	0.00018	0.00042	CcSEcCtD
Zopiclone—Headache—Risedronate—osteoporosis	0.000179	0.000419	CcSEcCtD
Zopiclone—Asthenia—Zoledronate—osteoporosis	0.000178	0.000416	CcSEcCtD
Zopiclone—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000176	0.000412	CcSEcCtD
Zopiclone—Pruritus—Zoledronate—osteoporosis	0.000175	0.000411	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000174	0.000407	CcSEcCtD
Zopiclone—Nausea—Ethinyl Estradiol—osteoporosis	0.000174	0.000407	CcSEcCtD
Zopiclone—Insomnia—Estradiol—osteoporosis	0.000173	0.000404	CcSEcCtD
Zopiclone—Vomiting—Pamidronate—osteoporosis	0.000173	0.000404	CcSEcCtD
Zopiclone—Paraesthesia—Estradiol—osteoporosis	0.000172	0.000402	CcSEcCtD
Zopiclone—Asthenia—Conjugated Estrogens—osteoporosis	0.000171	0.000401	CcSEcCtD
Zopiclone—Rash—Pamidronate—osteoporosis	0.000171	0.000401	CcSEcCtD
Zopiclone—Dermatitis—Pamidronate—osteoporosis	0.000171	0.0004	CcSEcCtD
Zopiclone—Dyspnoea—Estradiol—osteoporosis	0.00017	0.000399	CcSEcCtD
Zopiclone—Headache—Pamidronate—osteoporosis	0.00017	0.000398	CcSEcCtD
Zopiclone—Somnolence—Estradiol—osteoporosis	0.00017	0.000398	CcSEcCtD
Zopiclone—Diarrhoea—Zoledronate—osteoporosis	0.00017	0.000397	CcSEcCtD
Zopiclone—Nausea—Risedronate—osteoporosis	0.00017	0.000397	CcSEcCtD
Zopiclone—Pruritus—Conjugated Estrogens—osteoporosis	0.000169	0.000395	CcSEcCtD
Zopiclone—Dyspepsia—Estradiol—osteoporosis	0.000168	0.000394	CcSEcCtD
Zopiclone—Decreased appetite—Estradiol—osteoporosis	0.000166	0.000389	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Estradiol—osteoporosis	0.000165	0.000386	CcSEcCtD
Zopiclone—Fatigue—Estradiol—osteoporosis	0.000165	0.000386	CcSEcCtD
Zopiclone—Dizziness—Zoledronate—osteoporosis	0.000164	0.000384	CcSEcCtD
Zopiclone—Constipation—Estradiol—osteoporosis	0.000163	0.000382	CcSEcCtD
Zopiclone—Pain—Estradiol—osteoporosis	0.000163	0.000382	CcSEcCtD
Zopiclone—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000163	0.000382	CcSEcCtD
Zopiclone—Nausea—Pamidronate—osteoporosis	0.000161	0.000377	CcSEcCtD
Zopiclone—Dizziness—Conjugated Estrogens—osteoporosis	0.000158	0.00037	CcSEcCtD
Zopiclone—Vomiting—Zoledronate—osteoporosis	0.000158	0.000369	CcSEcCtD
Zopiclone—Feeling abnormal—Estradiol—osteoporosis	0.000158	0.000369	CcSEcCtD
Zopiclone—Rash—Zoledronate—osteoporosis	0.000156	0.000366	CcSEcCtD
Zopiclone—Gastrointestinal pain—Estradiol—osteoporosis	0.000156	0.000366	CcSEcCtD
Zopiclone—Dermatitis—Zoledronate—osteoporosis	0.000156	0.000366	CcSEcCtD
Zopiclone—Headache—Zoledronate—osteoporosis	0.000155	0.000364	CcSEcCtD
Zopiclone—Vomiting—Conjugated Estrogens—osteoporosis	0.000152	0.000355	CcSEcCtD
Zopiclone—Urticaria—Estradiol—osteoporosis	0.000152	0.000355	CcSEcCtD
Zopiclone—Abdominal pain—Estradiol—osteoporosis	0.000151	0.000354	CcSEcCtD
Zopiclone—Body temperature increased—Estradiol—osteoporosis	0.000151	0.000354	CcSEcCtD
Zopiclone—Rash—Conjugated Estrogens—osteoporosis	0.000151	0.000352	CcSEcCtD
Zopiclone—Dermatitis—Conjugated Estrogens—osteoporosis	0.00015	0.000352	CcSEcCtD
Zopiclone—Headache—Conjugated Estrogens—osteoporosis	0.00015	0.00035	CcSEcCtD
Zopiclone—Nausea—Zoledronate—osteoporosis	0.000147	0.000345	CcSEcCtD
Zopiclone—Nausea—Conjugated Estrogens—osteoporosis	0.000142	0.000332	CcSEcCtD
Zopiclone—Hypersensitivity—Estradiol—osteoporosis	0.000141	0.000329	CcSEcCtD
Zopiclone—Asthenia—Estradiol—osteoporosis	0.000137	0.000321	CcSEcCtD
Zopiclone—Pruritus—Estradiol—osteoporosis	0.000135	0.000316	CcSEcCtD
Zopiclone—Diarrhoea—Estradiol—osteoporosis	0.000131	0.000306	CcSEcCtD
Zopiclone—Dizziness—Estradiol—osteoporosis	0.000126	0.000296	CcSEcCtD
Zopiclone—Vomiting—Estradiol—osteoporosis	0.000122	0.000284	CcSEcCtD
Zopiclone—Rash—Estradiol—osteoporosis	0.000121	0.000282	CcSEcCtD
Zopiclone—Dermatitis—Estradiol—osteoporosis	0.00012	0.000282	CcSEcCtD
Zopiclone—Headache—Estradiol—osteoporosis	0.00012	0.00028	CcSEcCtD
Zopiclone—Nausea—Estradiol—osteoporosis	0.000114	0.000266	CcSEcCtD
Zopiclone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	1.65e-05	0.00548	CbGpPWpGaD
Zopiclone—PTGS1—Overview of nanoparticle effects—IL6—osteoporosis	1.64e-05	0.00544	CbGpPWpGaD
Zopiclone—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	1.63e-05	0.00541	CbGpPWpGaD
Zopiclone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	1.62e-05	0.00536	CbGpPWpGaD
Zopiclone—CYP2C8—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	1.59e-05	0.00529	CbGpPWpGaD
Zopiclone—PTGS1—Selenium Micronutrient Network—SOD2—osteoporosis	1.57e-05	0.00521	CbGpPWpGaD
Zopiclone—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	1.56e-05	0.00516	CbGpPWpGaD
Zopiclone—CYP2E1—Biological oxidations—CYP27A1—osteoporosis	1.53e-05	0.00508	CbGpPWpGaD
Zopiclone—CYP2C8—Arachidonic acid metabolism—GPX1—osteoporosis	1.52e-05	0.00505	CbGpPWpGaD
Zopiclone—CYP2E1—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	1.52e-05	0.00503	CbGpPWpGaD
Zopiclone—CYP2E1—Metapathway biotransformation—CYP27A1—osteoporosis	1.51e-05	0.00501	CbGpPWpGaD
Zopiclone—PTGS1—Selenium Micronutrient Network—GPX1—osteoporosis	1.5e-05	0.00497	CbGpPWpGaD
Zopiclone—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	1.46e-05	0.00483	CbGpPWpGaD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—ESR2—osteoporosis	1.44e-05	0.00477	CbGpPWpGaD
Zopiclone—GABRG3—Transmembrane transport of small molecules—ANXA2—osteoporosis	1.43e-05	0.00474	CbGpPWpGaD
Zopiclone—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	1.41e-05	0.00469	CbGpPWpGaD
Zopiclone—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	1.39e-05	0.00461	CbGpPWpGaD
Zopiclone—PTGS1—Selenium Micronutrient Network—MTHFR—osteoporosis	1.38e-05	0.00459	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	1.37e-05	0.00455	CbGpPWpGaD
Zopiclone—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	1.37e-05	0.00453	CbGpPWpGaD
Zopiclone—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	1.36e-05	0.0045	CbGpPWpGaD
Zopiclone—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	1.34e-05	0.00444	CbGpPWpGaD
Zopiclone—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	1.33e-05	0.00442	CbGpPWpGaD
Zopiclone—CYP2C8—Biological oxidations—CYP27A1—osteoporosis	1.32e-05	0.00439	CbGpPWpGaD
Zopiclone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	1.31e-05	0.00436	CbGpPWpGaD
Zopiclone—CYP2C8—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	1.31e-05	0.00435	CbGpPWpGaD
Zopiclone—CYP2C8—Metapathway biotransformation—CYP27A1—osteoporosis	1.31e-05	0.00433	CbGpPWpGaD
Zopiclone—GABRG3—Transmission across Chemical Synapses—ADCY5—osteoporosis	1.3e-05	0.00432	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	1.3e-05	0.00431	CbGpPWpGaD
Zopiclone—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	1.3e-05	0.00431	CbGpPWpGaD
Zopiclone—GABRB3—BDNF signaling pathway—SPP1—osteoporosis	1.28e-05	0.00426	CbGpPWpGaD
Zopiclone—CYP2C9—Arachidonic acid metabolism—GPX1—osteoporosis	1.24e-05	0.00411	CbGpPWpGaD
Zopiclone—PTGS1—Phase 1 - Functionalization of compounds—POMC—osteoporosis	1.22e-05	0.00404	CbGpPWpGaD
Zopiclone—GABRB2—Transmembrane transport of small molecules—ANXA2—osteoporosis	1.2e-05	0.00399	CbGpPWpGaD
Zopiclone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	1.19e-05	0.00396	CbGpPWpGaD
Zopiclone—GABRA5—Transmembrane transport of small molecules—ANXA2—osteoporosis	1.17e-05	0.00388	CbGpPWpGaD
Zopiclone—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	1.16e-05	0.00386	CbGpPWpGaD
Zopiclone—GABRB3—BDNF signaling pathway—IRS2—osteoporosis	1.16e-05	0.00385	CbGpPWpGaD
Zopiclone—GABRA3—Transmembrane transport of small molecules—ANXA2—osteoporosis	1.15e-05	0.00381	CbGpPWpGaD
Zopiclone—GABRA2—Transmembrane transport of small molecules—ANXA2—osteoporosis	1.13e-05	0.00374	CbGpPWpGaD
Zopiclone—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	1.12e-05	0.00373	CbGpPWpGaD
Zopiclone—GABRB3—Transmembrane transport of small molecules—ANXA2—osteoporosis	1.12e-05	0.00372	CbGpPWpGaD
Zopiclone—GABRG2—Transmembrane transport of small molecules—ANXA2—osteoporosis	1.1e-05	0.00365	CbGpPWpGaD
Zopiclone—GABRB2—Transmission across Chemical Synapses—ADCY5—osteoporosis	1.09e-05	0.00363	CbGpPWpGaD
Zopiclone—CYP2C9—Biological oxidations—CYP27A1—osteoporosis	1.08e-05	0.00358	CbGpPWpGaD
Zopiclone—PTGS1—Biological oxidations—CYP19A1—osteoporosis	1.08e-05	0.00357	CbGpPWpGaD
Zopiclone—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	1.07e-05	0.00356	CbGpPWpGaD
Zopiclone—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	1.07e-05	0.00354	CbGpPWpGaD
Zopiclone—GABRA5—Transmission across Chemical Synapses—ADCY5—osteoporosis	1.06e-05	0.00353	CbGpPWpGaD
Zopiclone—CYP2C9—Metapathway biotransformation—CYP27A1—osteoporosis	1.06e-05	0.00353	CbGpPWpGaD
Zopiclone—GABRA3—Transmission across Chemical Synapses—ADCY5—osteoporosis	1.04e-05	0.00347	CbGpPWpGaD
Zopiclone—GABRA2—Transmission across Chemical Synapses—ADCY5—osteoporosis	1.03e-05	0.00341	CbGpPWpGaD
Zopiclone—GABRB3—Transmission across Chemical Synapses—ADCY5—osteoporosis	1.02e-05	0.00338	CbGpPWpGaD
Zopiclone—GABRB3—BDNF signaling pathway—IRS1—osteoporosis	1.01e-05	0.00336	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	1.01e-05	0.00335	CbGpPWpGaD
Zopiclone—GABRG2—Transmission across Chemical Synapses—ADCY5—osteoporosis	1e-05	0.00332	CbGpPWpGaD
Zopiclone—GABRG3—Neuronal System—ADCY5—osteoporosis	9.96e-06	0.00331	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	9.85e-06	0.00327	CbGpPWpGaD
Zopiclone—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	9.71e-06	0.00322	CbGpPWpGaD
Zopiclone—GABRA1—Transmembrane transport of small molecules—ANXA2—osteoporosis	9.61e-06	0.00319	CbGpPWpGaD
Zopiclone—CYP2E1—Phase 1 - Functionalization of compounds—POMC—osteoporosis	9.11e-06	0.00302	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	8.85e-06	0.00294	CbGpPWpGaD
Zopiclone—GABRA1—Transmission across Chemical Synapses—ADCY5—osteoporosis	8.75e-06	0.0029	CbGpPWpGaD
Zopiclone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	8.67e-06	0.00288	CbGpPWpGaD
Zopiclone—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	8.56e-06	0.00284	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	8.39e-06	0.00279	CbGpPWpGaD
Zopiclone—GABRB2—Neuronal System—ADCY5—osteoporosis	8.39e-06	0.00278	CbGpPWpGaD
Zopiclone—PTGS1—Selenium Micronutrient Network—IL1B—osteoporosis	8.21e-06	0.00272	CbGpPWpGaD
Zopiclone—GABRA5—Neuronal System—ADCY5—osteoporosis	8.15e-06	0.0027	CbGpPWpGaD
Zopiclone—CYP2E1—Biological oxidations—CYP19A1—osteoporosis	8.05e-06	0.00267	CbGpPWpGaD
Zopiclone—GABRA3—Neuronal System—ADCY5—osteoporosis	8e-06	0.00266	CbGpPWpGaD
Zopiclone—CYP2E1—Metapathway biotransformation—CYP19A1—osteoporosis	7.94e-06	0.00263	CbGpPWpGaD
Zopiclone—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	7.9e-06	0.00262	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	7.87e-06	0.00261	CbGpPWpGaD
Zopiclone—CYP2C8—Phase 1 - Functionalization of compounds—POMC—osteoporosis	7.87e-06	0.00261	CbGpPWpGaD
Zopiclone—GABRA2—Neuronal System—ADCY5—osteoporosis	7.86e-06	0.00261	CbGpPWpGaD
Zopiclone—GABRB3—Neuronal System—ADCY5—osteoporosis	7.81e-06	0.00259	CbGpPWpGaD
Zopiclone—GABRG2—Neuronal System—ADCY5—osteoporosis	7.67e-06	0.00255	CbGpPWpGaD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—IL6R—osteoporosis	7.66e-06	0.00254	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	7.21e-06	0.00239	CbGpPWpGaD
Zopiclone—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	7.11e-06	0.00236	CbGpPWpGaD
Zopiclone—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	7.03e-06	0.00233	CbGpPWpGaD
Zopiclone—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	7.01e-06	0.00233	CbGpPWpGaD
Zopiclone—CYP2C8—Biological oxidations—CYP19A1—osteoporosis	6.96e-06	0.00231	CbGpPWpGaD
Zopiclone—CYP2C8—Metapathway biotransformation—CYP19A1—osteoporosis	6.86e-06	0.00228	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	6.83e-06	0.00227	CbGpPWpGaD
Zopiclone—GABRA1—Neuronal System—ADCY5—osteoporosis	6.7e-06	0.00223	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	6.69e-06	0.00222	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	6.53e-06	0.00217	CbGpPWpGaD
Zopiclone—PTGS1—Biological oxidations—POMC—osteoporosis	6.47e-06	0.00215	CbGpPWpGaD
Zopiclone—CYP2C9—Phase 1 - Functionalization of compounds—POMC—osteoporosis	6.41e-06	0.00213	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	6.36e-06	0.00211	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—PKM—osteoporosis	6.1e-06	0.00203	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—FDPS—osteoporosis	6.1e-06	0.00203	CbGpPWpGaD
Zopiclone—PTGS1—Selenium Micronutrient Network—TNF—osteoporosis	5.96e-06	0.00198	CbGpPWpGaD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—IL1B—osteoporosis	5.83e-06	0.00193	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—GPD2—osteoporosis	5.79e-06	0.00192	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—PGLS—osteoporosis	5.79e-06	0.00192	CbGpPWpGaD
Zopiclone—CYP2C9—Biological oxidations—CYP19A1—osteoporosis	5.66e-06	0.00188	CbGpPWpGaD
Zopiclone—CYP2C9—Metapathway biotransformation—CYP19A1—osteoporosis	5.58e-06	0.00185	CbGpPWpGaD
Zopiclone—GABRG3—Transmembrane transport of small molecules—ADCY5—osteoporosis	5.36e-06	0.00178	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	5.31e-06	0.00176	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—ATIC—osteoporosis	5.29e-06	0.00176	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—PNP—osteoporosis	5.29e-06	0.00176	CbGpPWpGaD
Zopiclone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	5.21e-06	0.00173	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	5.18e-06	0.00172	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	5.09e-06	0.00169	CbGpPWpGaD
Zopiclone—CYP2E1—Biological oxidations—POMC—osteoporosis	4.84e-06	0.00161	CbGpPWpGaD
Zopiclone—PTGS1—Selenium Micronutrient Network—IL6—osteoporosis	4.81e-06	0.0016	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PKM—osteoporosis	4.56e-06	0.00151	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—FDPS—osteoporosis	4.56e-06	0.00151	CbGpPWpGaD
Zopiclone—GABRB2—Transmembrane transport of small molecules—ADCY5—osteoporosis	4.51e-06	0.0015	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—CA2—osteoporosis	4.5e-06	0.00149	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—OXCT1—osteoporosis	4.5e-06	0.00149	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—MGLL—osteoporosis	4.39e-06	0.00146	CbGpPWpGaD
Zopiclone—GABRA5—Transmembrane transport of small molecules—ADCY5—osteoporosis	4.38e-06	0.00145	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PGLS—osteoporosis	4.32e-06	0.00144	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—GPD2—osteoporosis	4.32e-06	0.00144	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	4.32e-06	0.00143	CbGpPWpGaD
Zopiclone—GABRA3—Transmembrane transport of small molecules—ADCY5—osteoporosis	4.3e-06	0.00143	CbGpPWpGaD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—TNF—osteoporosis	4.23e-06	0.0014	CbGpPWpGaD
Zopiclone—GABRA2—Transmembrane transport of small molecules—ADCY5—osteoporosis	4.23e-06	0.0014	CbGpPWpGaD
Zopiclone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	4.22e-06	0.0014	CbGpPWpGaD
Zopiclone—GABRB3—Transmembrane transport of small molecules—ADCY5—osteoporosis	4.2e-06	0.00139	CbGpPWpGaD
Zopiclone—CYP2C8—Biological oxidations—POMC—osteoporosis	4.18e-06	0.00139	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	4.14e-06	0.00137	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	4.14e-06	0.00137	CbGpPWpGaD
Zopiclone—GABRG2—Transmembrane transport of small molecules—ADCY5—osteoporosis	4.12e-06	0.00137	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PNP—osteoporosis	3.96e-06	0.00131	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—ATIC—osteoporosis	3.96e-06	0.00131	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—FDPS—osteoporosis	3.94e-06	0.00131	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PKM—osteoporosis	3.94e-06	0.00131	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PGLS—osteoporosis	3.74e-06	0.00124	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—GPD2—osteoporosis	3.74e-06	0.00124	CbGpPWpGaD
Zopiclone—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	3.73e-06	0.00124	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—IDH2—osteoporosis	3.73e-06	0.00124	CbGpPWpGaD
Zopiclone—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	3.68e-06	0.00122	CbGpPWpGaD
Zopiclone—GABRA1—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.6e-06	0.0012	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	3.52e-06	0.00117	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—CYP27A1—osteoporosis	3.51e-06	0.00116	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PNP—osteoporosis	3.42e-06	0.00113	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—ATIC—osteoporosis	3.42e-06	0.00113	CbGpPWpGaD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—IL6—osteoporosis	3.41e-06	0.00113	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—ACP5—osteoporosis	3.41e-06	0.00113	CbGpPWpGaD
Zopiclone—CYP2C9—Biological oxidations—POMC—osteoporosis	3.4e-06	0.00113	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.37e-06	0.00112	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—CA2—osteoporosis	3.36e-06	0.00112	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—OXCT1—osteoporosis	3.36e-06	0.00112	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—MGLL—osteoporosis	3.28e-06	0.00109	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—FDPS—osteoporosis	3.21e-06	0.00107	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PKM—osteoporosis	3.21e-06	0.00107	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—TPI1—osteoporosis	3.17e-06	0.00105	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—GPD2—osteoporosis	3.04e-06	0.00101	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PGLS—osteoporosis	3.04e-06	0.00101	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—P4HB—osteoporosis	2.98e-06	0.000989	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—GAPDH—osteoporosis	2.93e-06	0.000971	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—CA2—osteoporosis	2.91e-06	0.000965	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—OXCT1—osteoporosis	2.91e-06	0.000965	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—RAP1A—osteoporosis	2.85e-06	0.000946	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—MGLL—osteoporosis	2.83e-06	0.00094	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—IDH2—osteoporosis	2.79e-06	0.000925	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PNP—osteoporosis	2.78e-06	0.000923	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—ATIC—osteoporosis	2.78e-06	0.000923	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.67e-06	0.000887	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—CYP27A1—osteoporosis	2.62e-06	0.00087	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—ACP5—osteoporosis	2.55e-06	0.000846	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.49e-06	0.000825	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—IDH2—osteoporosis	2.41e-06	0.000799	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—TPI1—osteoporosis	2.37e-06	0.000786	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—CA2—osteoporosis	2.37e-06	0.000785	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—OXCT1—osteoporosis	2.37e-06	0.000785	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—MGLL—osteoporosis	2.31e-06	0.000765	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—ENO1—osteoporosis	2.3e-06	0.000765	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—PSMA5—osteoporosis	2.27e-06	0.000753	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—PSMA2—osteoporosis	2.27e-06	0.000753	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—CYP27A1—osteoporosis	2.26e-06	0.000752	CbGpPWpGaD
Zopiclone—CYP3A4—Biological oxidations—POMC—osteoporosis	2.24e-06	0.000745	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—P4HB—osteoporosis	2.23e-06	0.000739	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—ACP5—osteoporosis	2.2e-06	0.000731	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—GAPDH—osteoporosis	2.19e-06	0.000726	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.18e-06	0.000722	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.17e-06	0.000722	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—RAP1A—osteoporosis	2.13e-06	0.000707	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PKM—osteoporosis	2.12e-06	0.000702	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—FDPS—osteoporosis	2.12e-06	0.000702	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—TPI1—osteoporosis	2.05e-06	0.00068	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—GPD2—osteoporosis	2.01e-06	0.000666	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PGLS—osteoporosis	2.01e-06	0.000666	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—IDH2—osteoporosis	1.96e-06	0.000651	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—P4HB—osteoporosis	1.93e-06	0.000639	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—GAPDH—osteoporosis	1.89e-06	0.000627	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—CYP27A1—osteoporosis	1.84e-06	0.000612	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—CYP19A1—osteoporosis	1.84e-06	0.000611	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—RAP1A—osteoporosis	1.84e-06	0.000611	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PNP—osteoporosis	1.83e-06	0.000609	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—ATIC—osteoporosis	1.83e-06	0.000609	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—ACP5—osteoporosis	1.79e-06	0.000595	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.77e-06	0.000588	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—ENO1—osteoporosis	1.72e-06	0.000571	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PSMA5—osteoporosis	1.7e-06	0.000563	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PSMA2—osteoporosis	1.7e-06	0.000563	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—TPI1—osteoporosis	1.67e-06	0.000553	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.61e-06	0.000533	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—P4HB—osteoporosis	1.57e-06	0.00052	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—CA2—osteoporosis	1.56e-06	0.000518	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—OXCT1—osteoporosis	1.56e-06	0.000518	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—GAPDH—osteoporosis	1.54e-06	0.000511	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—MGLL—osteoporosis	1.52e-06	0.000505	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—ADCY5—osteoporosis	1.5e-06	0.000499	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—GPX1—osteoporosis	1.5e-06	0.000498	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—RAP1A—osteoporosis	1.5e-06	0.000497	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—ENO1—osteoporosis	1.49e-06	0.000494	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PSMA5—osteoporosis	1.47e-06	0.000487	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PSMA2—osteoporosis	1.47e-06	0.000487	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—MTHFR—osteoporosis	1.38e-06	0.000459	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—CYP19A1—osteoporosis	1.38e-06	0.000457	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.31e-06	0.000434	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—IDH2—osteoporosis	1.29e-06	0.000429	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.22e-06	0.000403	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—ENO1—osteoporosis	1.21e-06	0.000402	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PSMA2—osteoporosis	1.19e-06	0.000396	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PSMA5—osteoporosis	1.19e-06	0.000396	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—CYP19A1—osteoporosis	1.19e-06	0.000395	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—ACP5—osteoporosis	1.18e-06	0.000392	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—ADCY5—osteoporosis	1.12e-06	0.000373	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—GPX1—osteoporosis	1.12e-06	0.000372	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—POMC—osteoporosis	1.11e-06	0.000367	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—TPI1—osteoporosis	1.1e-06	0.000365	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—MTHFR—osteoporosis	1.03e-06	0.000343	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—P4HB—osteoporosis	1.03e-06	0.000343	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—GAPDH—osteoporosis	1.01e-06	0.000337	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—RAP1A—osteoporosis	9.88e-07	0.000328	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—ADCY5—osteoporosis	9.72e-07	0.000323	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—GPX1—osteoporosis	9.69e-07	0.000321	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—CYP19A1—osteoporosis	9.68e-07	0.000321	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—MTHFR—osteoporosis	8.94e-07	0.000297	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—POMC—osteoporosis	8.27e-07	0.000275	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—ENO1—osteoporosis	7.99e-07	0.000265	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—ADCY5—osteoporosis	7.91e-07	0.000263	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—GPX1—osteoporosis	7.88e-07	0.000262	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PSMA5—osteoporosis	7.87e-07	0.000261	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PSMA2—osteoporosis	7.87e-07	0.000261	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—MTHFR—osteoporosis	7.28e-07	0.000241	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—POMC—osteoporosis	7.15e-07	0.000237	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—CYP19A1—osteoporosis	6.39e-07	0.000212	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—POMC—osteoporosis	5.82e-07	0.000193	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—ADCY5—osteoporosis	5.22e-07	0.000173	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—GPX1—osteoporosis	5.2e-07	0.000173	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—MTHFR—osteoporosis	4.8e-07	0.000159	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—POMC—osteoporosis	3.84e-07	0.000127	CbGpPWpGaD
